Stephens Inc Glaukos Corp Transaction History
Stephens Inc
- $6.84 Billion
- Q4 2024
A detailed history of Stephens Inc transactions in Glaukos Corp stock. As of the latest transaction made, Stephens Inc holds 1,749 shares of GKOS stock, worth $178,730. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,749
Previous 1,797
2.67%
Holding current value
$178,730
Previous $234,000
11.97%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding GKOS
# of Institutions
355Shares Held
50.1MCall Options Held
282KPut Options Held
401K-
Black Rock Inc. New York, NY8.04MShares$821 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.97MShares$611 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA2.16MShares$221 Million0.06% of portfolio
-
State Street Corp Boston, MA2.06MShares$211 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.93MShares$197 Million0.08% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $4.86B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...